In vitro evaluation of acute cytotoxicity of human chemically treated allografts

European Cells and Materials

Volumn 1, Issue , 2001, Pages 52-58

  Dufrane, D ^a   Cornu, O ^a   Verraes, T ^a   Schecroun, N ^a   Banse, X ^a   Schneider, Y J ^a   Delloye, Ch ^a   Jansen, J A ^b   Grant, M H ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b NONE

Author keywords

Allografts; Biocompatibility; Cytotoxicity; in vitro studies; Virus inactivation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROMIDE; TETRAZOLIUM; TISSUE EXTRACT;

ALLOGRAFT; ARTICLE; ASSAY; BONE; CELL CULTURE; CELL LINE; CELL STRUCTURE; CELL SWELLING; CELL TYPE; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; DURA MATER; FASCIA LATA; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NERVE CELL; OSTEOBLAST; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

EID: 3242722355     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v001a06     Document Type: Article

References (38)

1. Borenfreund E, Babich H, Martin-Alguacil N (1988) Comparison of two in vitro cytotoxic assays - The neutral red (NR) and tetrazolium MTT tests. Toxicol in Vitro 2: 1-6.
2. Brown P, Gibbs CJ, Amyx HL, Kingsbury DT, Rohwer RG, Sulima MP, Gajdusek DC (1982) Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 306: 1279-1282.
3. Brown P, Rohwer RG, Gajdusek DC (1984) Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus. N Engl J Med 310: 727.
4. Buck BE, Malinin TI, Brown MD (1989) Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS). Clin Orthop 240: 129-136.
5. Campbell DG, Oakeshott RD (1995) Bone allograft banking in South Australia. Aust N Z J Surg 65: 865-869.
6. Campbell DG, Peng Li, Stephenson AJ, Oakeshott RD (1994) Sterilization of HIV by gamma irradiation. International Orthopaedics 18: 172-176.
7. Clifford CJ, Downes S (1996) A comparative study of the use of colorimetric assays in the assessment of biocompatibility. J Mater Sci Mater Med 7: 637-643.
8. Conrad EU, Gretch DR, Obermeyer KR, Moogk MS, Sayers M, Wilson JJ (1995) Transmission of the hepatitis C virus by tissue transplantation. J Bone Joint Surg 77A: 214-224.
9. Conway B, Tomford W, Mankin HJ, Hirsch MS, Schooley RT (1991) Radiosensitivity of HIV-1. Potential application to sterilization of bone allografts. AIDS 5: 608-609.
10. Dekker A, Panfil C, Valdor M, Pennartz G, Richter H, Mittermayer Ch, Kirkpatrick CJ (1994) Quantitative methods for in vitro cytotoxicity testing of biomaterials. Cells Mater 4: 101-112.
11. Delloye C (1994) Tissue allografts and health risks. Acta Ortopaed Belgica 60: 62-67.
12. Dormont D (1996) Creutzfeldt-Jakob disease and transplantation: facts and fables. Transpl Proc 28: 2931-2933.
13. Eggen BM, Nordbo SA (1992) Transmission of HCV by organ transplantation. N Engl J Med 326: 412-413.
14. 2 for bone delipidation. Biomaterials 15: 650-656.
15. Feinstone S, Mihalik K, Kanimura T (1983) Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun 41: 816-821.
16. Fideler BM, Vangsness T, Moore T, Li Z, Rasheed S (1994) Effects of gamma irradiation on the human immunodeficiency virus. A study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavera. J Bone Joint Surg 76A: 1032-1035.
17. Forsell J (1993) Irradiation of musculoskeletal tissues. In: Musculoskeletal Tissue Banking. Tomford W (ed.). Raven Press. pp. 149-180.
18. Hernigou P, Marce D, Julieron A, Marinello G, Dormont D (1993) Sterilisation osseuse par irradiation et VIH. Rev Chir Orthop 79: 445-451.
19. Johnson HJ, Northup SJ, Seagraves PA, Atallah M, Garvin PJ, Lin L, Darby TD (1985) Biocompatibility test procedures for materials evaluation in vitro. II. Objective methods of toxicity assessment. J Biomed Mater Res 19: 489-508.
20. Kearney J, Bojar R, Holland K (1993) Ethylene oxide sterilisation of allogenic bone implants. Clin Mater 12: 129-135.
21. Kirkpatrick CJ, Mittermayer C (1990). Theoretical and practical aspects of testing potential biomaterials in vitro. J Mater Sci Mater Med 1: 9-13.
22. Kirkpatrick CJ, Bittinger F, Wagner M, Köhler H, van Kooten TG, Klein CL, Otto M (1997a) Current trends in biocompatibility testing. Proc Instn Mech Engrs 212 Part H: 75-84.
23. Kirkpatrick CJ, Wagner M, Köhler H, Bittinger F, Otto M, Klein CL (1997b) The cell and molecular biological approach to biomaterial research: a perspective. J Mater Sci Mater Med 8: 131-141.
24. Lasarow RM, Rivkah Isseroff R, Gomez EC (1992). Quantitative in vitro assessment of phototoxicity by fibroblast - neutral red assay. J Invest Dermatol 98: 725-729.
25. Lelie PN, Zaaijer HL, Cuypers HT (1996) Risk of virus transmission by tissue, blood and plasma products. Transplant Proc 28: 2939.
26. Loty B, Courpied J, Tomeno B, Postel M, Forest M, Abelanet R (1990) Radiation sterilized bone allografts. Int Orthop 14: 237-242.
27. Macnair R, Rodgers EH, Macdonald C, Wykman A, Goldie I, Grant MH (1997) The response of primary rat and human osteoblasts and an immortalized rat osteoblast cell line to orthopaedic materials: comparative sensitivity of several toxicity indices. J Mater Sci Mater Med 8: 105-111.
28. Marshall NJ, Goodwin CJ, Holt SJ (1995) A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul 5: 69-84.
29. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
30. Pariente JL, Bordenave L, Bareille R, Rouais F, Courtes C, Daude G, le Guillou M, Baquey C (1998) First use of cultured human urothelial cells for biocompatibility assessment: Application to urinary catheters. J Biomed Mater Res 40: 29-37.
31. Spire B, Barre-Sinoussi F, Montagnier L, Chermann JC (1984) Inactivation of lymphadenopathy associated virus by chemical desinfectants. Lancet 2: 899-901.
32. Spire B, Dormont D, Barré-Sinoussi F, Montagnier L, Chermann JC (1985) Inactivation of lymphadeno-pathy-associated virus by heat, gamma rays and ultraviolet light. Lancet 2: 188-189.
33. Srivastava S, Gorham SD, Courtney JM (1990) Screening of in vitro cytotoxicity by the adhesive film test. Biomaterials 11: 133-137.
34. Ulreich JB, Chvapil M (1981) A quantitative microassay for in vitro toxicity testing of biomaterials. J Biomed Mater Res 15: 913-922.
35. Verhulst C, Coiffard C, Coiffard LJM, Rivalland P, De Roeck-Holtzhauer Y (1998) In vitro correlation between two colorimetric assays and the pyruvic acid consumption by fibroblasts cultured to determine the sodium laurylsulfate cytotxicity. J Pharmacol Toxicol Methods 39: 143-146.
36. World Health Organization (1992) Report of a WHO Consultation on Public Health Issues Related to Animal and Human Spongiform Encephalopathies. WHO/CDS/ VPH/92.104.
37. Zhang Q, Cornu O, Delloye C (1997) Ethylene oxide does not extinguish the osteoinductive capacity of demineralized bone. Acta Orthop Scand 68: 104-108.
38. Zhang SZ, Lipsky M, Trump B, Hsu IC (1990) Neutral red assay for cell viability and xenobiotic-induced cytotoxicity in primary cultures of human and rat hepatocytes. Cell Biol Toxicol 6: 219-234.